Use of antithrombotic therapy according to CHA2DS2-VASc score in patients with atrial fibrillation in primary care
- PMID: 24795129
- DOI: 10.1016/j.rec.2013.07.009
Use of antithrombotic therapy according to CHA2DS2-VASc score in patients with atrial fibrillation in primary care
Comment in
-
Does CHA₂DS₂-VASc score select patients who will benefit most from anticoagulation?Rev Esp Cardiol (Engl Ed). 2014 May;67(5):417-8. doi: 10.1016/j.rec.2014.01.005. Epub 2014 Apr 3. Rev Esp Cardiol (Engl Ed). 2014. PMID: 24774741 No abstract available.
-
Does CHA₂DS₂-VASc score select patients who will benefit most from anticoagulation? Response.Rev Esp Cardiol (Engl Ed). 2014 May;67(5):418. doi: 10.1016/j.rec.2014.01.009. Epub 2014 Apr 3. Rev Esp Cardiol (Engl Ed). 2014. PMID: 24774742 No abstract available.
-
Use of antithrombotic therapy in patients with atrial fibrillation in primary care. Importance of INR control.Rev Esp Cardiol (Engl Ed). 2014 May;67(5):419. doi: 10.1016/j.rec.2014.02.003. Epub 2014 Apr 3. Rev Esp Cardiol (Engl Ed). 2014. PMID: 24774743 No abstract available.
-
Use of antithrombotic therapy in patients with atrial fibrillation in primary care. Importance of INR control. Response.Rev Esp Cardiol (Engl Ed). 2014 May;67(5):420. doi: 10.1016/j.rec.2014.03.001. Epub 2014 Apr 5. Rev Esp Cardiol (Engl Ed). 2014. PMID: 24774744 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical